Search - tctmd.com

Displaying 281 - 300 of 486

Sort: Relevancy | Date

Presentation TCT 2016

TCT 58: Long-term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Scaffolds During Daily Practice Two-Year Results From the ISAR-ABSORB Registry

Presenter: Antonio L. Bartorelli, Kenneth Chin, Jens Wiebe

October 31, 2016

Presentation TCT 2016

TCT 57: Impact of Lesion Length on One-Year Outcomes of Absorb Bioresorbable Vascular Scaffolds

Presenter: Antonio L. Bartorelli, Kenneth Chin, Rony Lahoud

October 31, 2016

Presentation TCT 2016

TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and Four-Year Clinical and Imaging Results

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

TCT 31: Impact of Strut Thickness on Short-term Healing Response After Bioresorbable Scaffold Implantation: Serial OCT Evaluation of Novel Thin Strut Sirolimus-Eluting BRS vs Thick Strut Everolimus-Eluting BRS in Porcine Coronary Arteries

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Pawel Gasior

October 31, 2016

Presentation TCT 2016

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Michael Haude

October 31, 2016

Presentation TCT 2016

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Jo Simonsen

October 31, 2016

Presentation TCT 2016

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Jo Simonsen

October 31, 2016

Presentation TCT 2016

Conclusion and Take-home Message

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Late Bioresorbable Scaffold Malapposition and Aneurysm

Presenter: Teguh Santoso, Wasan Udayachalerm, Jun-Jack Cheng

October 30, 2016

Presentation TCT 2016

Treatment of In-Stent Restenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Treatment of Bifurcation Stenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Treatment of Chronic Total Occlusions

Presenter: Teguh Santoso, Wasan Udayachalerm, Naoki Masuda

October 30, 2016

Presentation TCT 2016

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Presenter: Mohamed Abdel-Wahab, Philippe Généreux, Manuel Pan

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Azeem Latib

October 30, 2016

Presentation TCT 2016

Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More

Presenter: Koen Deloose, Jihad A. Mustapha

October 30, 2016

Presentation TCT 2016

Case Presentations: How to Use IVUS to Optimize Bioresorbable Scaffold Implantation

Presenter: Antonio Colombo, Gary S. Mintz

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Maurizio Menichelli

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Ashok Seth

October 30, 2016

Presentation SOLACI 2016

Complex PCI with BioResorbable Scaffolds

Presenter: Cristiano Guedes

June 09, 2016

Presentation

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

Presenter: Sripal Bangalore

March 29, 2016

Advertisement

TCT 58: Long-term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Scaffolds During Daily Practice Two-Year Results From the ISAR-ABSORB Registry

TCT 57: Impact of Lesion Length on One-Year Outcomes of Absorb Bioresorbable Vascular Scaffolds

TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and Four-Year Clinical and Imaging Results

TCT 31: Impact of Strut Thickness on Short-term Healing Response After Bioresorbable Scaffold Implantation: Serial OCT Evaluation of Novel Thin Strut Sirolimus-Eluting BRS vs Thick Strut Everolimus-Eluting BRS in Porcine Coronary Arteries

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Conclusion and Take-home Message

Late Bioresorbable Scaffold Malapposition and Aneurysm

Treatment of In-Stent Restenosis

Treatment of Bifurcation Stenosis

Treatment of Chronic Total Occlusions

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More

Case Presentations: How to Use IVUS to Optimize Bioresorbable Scaffold Implantation

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

Complex PCI with BioResorbable Scaffolds

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content